Search

everythinglearnresearchcommunity

for

Search:↓

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Post-finasteride syndrome's existence is uncertain; more research needed.

Topical finasteride with EGCG or TA improves drug release and dermal uptake, potentially treating hair loss effectively.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Delayed ejaculation is a complex issue caused by psychological, biological, and lifestyle factors, requiring a holistic treatment approach.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Older adults still engage in sexual activities but face challenges like health issues and lack of professional support, highlighting the need for better healthcare provider education and research on sexual fulfillment in old age.

Veterinarians could test positive for ketamine from work exposure, not just substance abuse.

The new delivery method for dutasteride is more effective and has fewer side effects.

Low testosterone does not prevent prostate cancer in men with type 1 diabetes.

Taking dutasteride for one month before prostate surgery can reduce bleeding.

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

Tamsulosin for enlarged prostate may increase the risk of severe low blood pressure, especially when starting or restarting the medication.

Finasteride before TURP reduces blood loss and improves early postoperative quality of life.

Mice without the vitamin D receptor have bone issues and other health problems, suggesting vitamin D is important for preventing various diseases in humans.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Fat tissue-derived cells show promise for repairing body tissues, but more research and regulation are needed for safe use.

Minoxidil and finasteride treat hair loss in men, while minoxidil treats hair loss in women.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Drug addicts often have scars, skin color changes, blocked veins, and bruising, with severe ulcers from barbiturate injections.

The 2018 update to the ED care model added a new severity score and stressed a detailed evaluation of both physical and psychological aspects.

Tumescent liposuction is safe and effective for different cosmetic surgeries if done within recommended limits.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

5ARIs like finasteride can help prevent prostate cancer and treat BPH, but guidelines should be updated to reflect this.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

Women with PCOS tend to be less optimistic than those without it.

Diseases have a big social impact in Nordic countries, affecting healthcare decisions.

A group has developed therapies that show promise for treating cancer and various other conditions.

Platelet-rich plasma therapy may have benefits and is generally safe, but more research is needed to confirm its effectiveness and safety.